Shoei Corporation (9385.T)
JPY 570.0
(-0.18%)
JPY 570.0
(-0.18%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 19.44 Billion | 20.74 Billion | 19.26 Billion | 20.5 Billion | 19.11 Billion | 17.8 Billion |
| Cost of Revenue | 15.36 Billion | 17.06 Billion | 15.4 Billion | 16.04 Billion | 15.45 Billion | 14.49 Billion |
| Gross Profit | 4.07 Billion | 3.68 Billion | 3.86 Billion | 4.46 Billion | 3.65 Billion | 3.31 Billion |
| Operating Expenses | 3.31 Billion | 3.53 Billion | 3.69 Billion | 3.24 Billion | 3.03 Billion | 2.78 Billion |
| Selling, General and Administrative Expenses | 3.31 Billion | 3.53 Billion | 3.69 Billion | 3.34 Billion | 3.04 Billion | 2.79 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | -4.7 Million | -76.16 Million | -244 Thousand | -9000.00 | 2.57 Million |
| Cost and Expenses | 18.68 Billion | 20.59 Billion | 19.09 Billion | 19.29 Billion | 18.48 Billion | 17.27 Billion |
| Operating Income | 760.72 Million | 154.23 Million | 176.11 Million | 1.21 Billion | 628.17 Million | 532.22 Million |
| Interest Expense | 25.81 Million | 33.68 Million | 25.37 Million | 25.59 Million | 40.36 Million | 39.15 Million |
| Income Tax Expense | 378.41 Million | -363.45 Million | 103.71 Million | 395.7 Million | 207.1 Million | 181.88 Million |
| Earnings before Tax | 1.38 Billion | -1.98 Billion | 168.98 Million | 1.07 Billion | 613.16 Million | 499.53 Million |
| Net Income | 1 Billion | -1.61 Billion | 89.3 Million | 675.18 Million | 406.06 Million | 317.64 Million |
| Earnings Per Share Basic | 130.59 | -209.30 | 11.56 | 100.55 | 64.01 | 48.66 |
| Earnings Per Share Diluted | 130.59 | -209.30 | 11.56 | 100.55 | 64.01 | 48.66 |
| Weighted Average Shares Outstanding | 7.72 Million | 7.72 Million | 7.72 Million | 6.71 Million | 6.34 Million | 6.52 Million |
| Weighted Average Shares Outstanding (Diluted) | 7.72 Million | 7.72 Million | 7.72 Million | 6.71 Million | 6.34 Million | 6.52 Million |
| Gross Margin | 0.21 | 0.18 | 0.20 | 0.22 | 0.19 | 0.19 |
| EBIT Margin | 0.09 | 0.03 | 0.03 | 0.07 | 0.04 | 0.04 |
| Profit Margin | 0.05 | -0.08 | 0.00 | 0.03 | 0.02 | 0.02 |
| EBITDA | 1.65 Billion | -1.56 Billion | 554.89 Million | 1.29 Billion | 842.12 Million | 671.1 Million |
| Earnings Before Tax Margin | 0.04 | 0.01 | 0.01 | 0.06 | 0.03 | 0.03 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 4.74 Billion | 4.7 Billion | 19.44 Billion | 5 Billion | 4.75 Billion | 4.98 Billion |
| Cost of Revenue | 3.68 Billion | 3.75 Billion | 15.36 Billion | 3.93 Billion | 3.72 Billion | 3.95 Billion |
| Gross Profit | 1.06 Billion | 955.32 Million | 4.07 Billion | 1.07 Billion | 1.02 Billion | 1.02 Billion |
| Operating Expenses | 860.85 Million | 761.12 Million | 3.31 Billion | 823.49 Million | 864.28 Million | 853.86 Million |
| Selling, General and Administrative Expenses | 860.85 Million | 761.12 Million | - | 823.49 Million | 868.85 Million | 862 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | -4.47 Million | 4.02 Million | 1.97 Million | 6.53 Million | -2000.00 |
| Cost and Expenses | 4.54 Billion | 4.51 Billion | 18.68 Billion | 4.75 Billion | 4.59 Billion | 4.8 Billion |
| Operating Income | 208.08 Million | 194.19 Million | 760.72 Million | 247.07 Million | 157.97 Million | 175.75 Million |
| Interest Expense | 6.23 Million | 5.46 Million | 25.81 Million | 5.79 Million | 7.28 Million | 7.28 Million |
| Income Tax Expense | 86.98 Million | 42.63 Million | 378.41 Million | 88.85 Million | 101.75 Million | 145.16 Million |
| Earnings before Tax | 219.47 Million | -87.38 Million | 1.38 Billion | 280.36 Million | 473.76 Million | 720.79 Million |
| Net Income | 132.48 Million | -130.02 Million | 1 Billion | 191.5 Million | 372.01 Million | 575.62 Million |
| Earnings Per Share Basic | 17.15 | -16.83 | - | 24.78 | 48.14 | 74.49 |
| Earnings Per Share Diluted | 17.15 | -16.83 | - | 24.78 | 48.14 | 74.49 |
| Weighted Average Shares Outstanding | 7.72 Million | 7.72 Million | 7.72 Million | 7.72 Million | 7.72 Million | 7.72 Million |
| Weighted Average Shares Outstanding (Diluted) | 7.72 Million | 7.72 Million | 7.72 Million | 7.72 Million | 7.72 Million | 7.72 Million |
| Gross Margin | 0.23 | 0.20 | 0.21 | 0.21 | 0.22 | 0.21 |
| EBIT Margin | 0.05 | 0.05 | - | 0.06 | 0.04 | 0.04 |
| Profit Margin | 0.03 | -0.03 | 0.05 | 0.04 | 0.08 | 0.12 |
| EBITDA | 251.8 Million | 256.58 Million | - | 307.94 Million | 169.99 Million | 182.19 Million |
| Earnings Before Tax Margin | 0.04 | 0.04 | 0.04 | 0.05 | 0.03 | 0.04 |
8030
8060
1468
PRIMESECU
AUROPHARMA
3075